Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.
Roshal Imaging Services is a provider of on-site and portable diagnostic Vascular and General body (OB/Gyn) ultrasound services.
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Medical Informatics offers solutions that give care teams access to the data they need to take action for alarm management and safety.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
PinkDx is a biotechnology company.
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
Medra AI develops an autonomous scientific experimentation platform that combines robotics with artificial intelligence.
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.
Sentonix is a pharmaceutical company that offers immuno-therapy service for cancer treatment.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Volta Labs develops scalable automation for genetic engineering.
Catalio Capital Management has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 21 different industry categories.
Among tracked funding rounds, Aviceda Therapeutics received $207.5M in a Series C round. Catalio Capital Management's total known invested capital is $12.7B.
Catalio Capital Management's average investment size is $93.1M across its portfolio of 132 companies.
Recent Catalio Capital Management portfolio additions include SetPoint Medical, Avalyn Pharma, Syndeio Biosciences, GlycoEra, Imbria Pharmaceuticals. These companies were founded in 2020 or later.